Jeisys Medical Inc. (KOSDAQ: 287410)

Jeisys Medical Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct 10, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	959,371	789,504	606,355	552,979	-
Market Cap Growth	23.01%	30.20%	9.65%	-	-
Enterprise Value	950,478	763,032	587,297	537,636	-
Last Close Price	12880.00	10490.00	8520.00	7770.00	-
PE Ratio	35.58	32.55	23.01	43.98	-
PS Ratio	5.87	5.52	5.20	6.80	-
PB Ratio	8.73	8.20	7.58	11.60	-
P/FCF Ratio	88.19	42.94	47.29	30.87	-
P/OCF Ratio	32.11	24.16	24.01	27.24	-
EV/Sales Ratio	5.66	5.33	5.04	6.61	-
EV/EBITDA Ratio	22.26	18.80	15.89	20.62	-
EV/EBIT Ratio	24.91	21.01	17.32	22.78	-
EV/FCF Ratio	87.37	41.50	45.80	30.02	-
Debt / Equity Ratio	0.62	0.27	0.20	0.26	0.74
Debt / EBITDA Ratio	1.65	0.63	0.44	0.47	0.95
Debt / FCF Ratio	6.47	1.39	1.27	0.69	0.92
Asset Turnover	0.99	1.10	1.21	1.44	-
Inventory Turnover	2.08	2.05	2.39	3.02	-
Quick Ratio	1.53	2.72	1.90	1.73	1.69
Current Ratio	2.00	3.85	2.80	2.25	2.19
Return on Equity (ROE)	27.29%	28.50%	42.34%	42.59%	-
Return on Assets (ROA)	14.09%	17.43%	22.06%	26.06%	-
Return on Capital (ROIC)	16.20%	20.82%	27.14%	32.96%	-
Earnings Yield	2.81%	3.14%	4.47%	2.46%	-
FCF Yield	1.13%	2.33%	2.11%	3.24%	-
Buyback Yield / Dilution	-0.33%	-0.93%	0.42%	-40.97%	-
Total Shareholder Return	-0.33%	-0.93%	0.42%	-40.97%	-

Source: S&P Capital IQ. Standard template. Financial Sources.